Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$284M |
| 2 |
Constellation Brands
STZ
|
+$284M |
| 3 |
Stellantis
STLA
|
+$268M |
| 4 |
VMW
VMware, Inc
VMW
|
+$263M |
| 5 |
NiSource
NI
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.82B |
| 2 |
Apple
AAPL
|
+$1.62B |
| 3 |
UnitedHealth
UNH
|
+$1.03B |
| 4 |
ExxonMobil
XOM
|
+$869M |
| 5 |
Tesla
TSLA
|
+$701M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.19% |
| 2 | Consumer Discretionary | 5.03% |
| 3 | Healthcare | 4.78% |
| 4 | Financials | 4.74% |
| 5 | Communication Services | 2.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HDSN
3701
Hudson Technologies
HDSN
$254M
| $190K | ﹤0.01% |
21,816
+10,234
| +88% | +$99.1K |
|
3702
Stoke Therapeutics
STOK
$1.8B
| $190K | ﹤0.01% |
22,860
+4,417
| +24% | +$39.9K |
|
|
SOHU
3703
Sohu.com
SOHU
$362M
| $190K | ﹤0.01% |
12,921
| – | – |
|
|
NEWR
3704
DELISTED
New Relic, Inc.
NEWR
| $190K | ﹤0.01% |
2,524
-13,901
| -85% | -$939K |
|
|
FIRY
3705
Firy Inc
FIRY
$148M
| $190K | ﹤0.01% |
15,989
+5,077
| +47% | +$67.3K |
|
3706
Aspen Aerogels
ASPN
$384M
| $189K | ﹤0.01% |
25,426
+17,073
| +204% | +$170K |
|
3707
J. Jill
JILL
$272M
| $189K | ﹤0.01% |
+7,271
| New | +$192K |
|
3708
Biglari Holdings Class B
BH
$1.25B
| $188K | ﹤0.01% |
1,113
-202
| -15% | -$33.4K |
|
3709
Skyward Specialty Insurance
SKWD
$2.43B
| $187K | ﹤0.01% |
+8,567
| New | +$166K |
|
3710
Purple Innovation
PRPL
$35.3M
| $187K | ﹤0.01% |
2,837
+687
| +32% | +$76.6K |
|
3711
Republic Bancorp
RBCAA
$1.95B
| $187K | ﹤0.01% |
4,408
+2,071
| +89% | +$89.3K |
|
3712
Edgewise Therapeutics
EWTX
$4.13B
| $187K | ﹤0.01% |
28,016
+9,783
| +54% | +$90.7K |
|
3713
Babcock & Wilcox
BW
$1.39B
| $187K | ﹤0.01% |
30,830
+14,414
| +88% | +$88.9K |
|
|
CALB
3714
DELISTED
California BanCorp Common Stock
CALB
| $187K | ﹤0.01% |
9,575
| – | – |
|
3715
MediaAlpha
MAX
$758M
| $187K | ﹤0.01% |
12,468
+5,851
| +88% | +$79.1K |
|
3716
Pennant Group
PNTG
$1.4B
| $187K | ﹤0.01% |
13,061
+61
| +0.5% | +$764 |
|
3717
IES Holdings
IESC
$14.8B
| $186K | ﹤0.01% |
4,327
+1,978
| +84% | +$81.2K |
|
|
ACB
3718
Aurora Cannabis
ACB
$173M
| $186K | ﹤0.01% |
26,657
+1,507
| +6% | +$13.2K |
|
3719
Frontier Group Holdings
ULCC
$1.55B
| $186K | ﹤0.01% |
18,871
+8,852
| +88% | +$98.8K |
|
3720
CALL
CSX Corp
CSX
$93.4B
| $186K | ﹤0.01% |
6,200
| – | – |
|
3721
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$224M
| $185K | ﹤0.01% |
160
+71
| +80% | +$95.1K |
|
3722
NWPX Infrastructure Inc
NWPX
$1.19B
| $185K | ﹤0.01% |
5,935
+3,311
| +126% | +$119K |
|
3723
Vanguard Total World Stock ETF
VT
$77.1B
| $184K | ﹤0.01% |
2,000
| – | – |
|
3724
Omega Flex
OFLX
$297M
| $184K | ﹤0.01% |
1,652
+775
| +88% | +$84.1K |
|
|
KNTE
3725
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $184K | ﹤0.01% |
29,425
+5,039
| +21% | +$30.7K |
|
Similar funds
Barclays's Q1 2023 Portfolio in Review
As of Q1 2023, Barclays held 5,603 positions worth $218B, down 2.4% from $223B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Barclays withdrew a net $25.1B in Q1 2023, closing 541 positions and reducing 1,667 holdings. Its most notable exit was Coupa Software Incorporated, an estimated $128M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Barclays opened a new position in GE HealthCare worth $40.7M.
- Barclays's largest Q1 2023 buy was GE HealthCare: 496,712 shares worth $40.7M.
- Barclays added most to State Street SPDR S&P Biotech ETF in Q1 2023, an estimated $284M increase.
- Barclays's biggest Q1 2023 reduction was Microsoft, cutting an estimated $1.82B.
- Barclays fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $128M.
- Barclays's ten largest holdings make up 47% of its $218B portfolio in Q1 2023.
- Barclays opened 345 new positions and closed 541 in Q1 2023.
- Barclays's portfolio value fell 2.4% quarter-over-quarter to $218B.
Based on Barclays's 13F filing for Q1 2023, filed 4 May 2023.